STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8
Clinical trials for STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy trial offers hope for HIV patients with advanced cancers
Disease control OngoingThis is a small, early-stage safety study testing a combination of two cancer drugs, nivolumab and cabozantinib, in people living with HIV who have advanced solid tumors. The main goal is to see if the two-drug combination is safe and tolerable for this specific patient group. Re…
Matched conditions: STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Could tighter blood pressure control make cancer treatment safer?
Disease control OngoingThis study is testing whether keeping blood pressure very low (under 120) is better than the usual target (under 140) for patients with advanced kidney or thyroid cancer who are starting specific cancer drugs. The goal is to see if this intensive approach is doable, safe, and hel…
Matched conditions: STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8
Phase: NA • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC